New Initiative
Senotherapeutics Biomarker Consortium
A multistakeholder initiative uniting academia, biotech, pharma and regulators to develop, standardize and validate senescence biomarkers. Announced at the 2nd SenoTherapeutics Summit and the 10th ICSA Annual Meeting, the SBC is coordinated by the Phaedon Institute through topic-specific working groups.
Inaugural SBC Summit · December 7, 2026 · Stanford University











